NCT05217771 (WHO) is a NA clinical trial of High tone power therapy group in Rehabilitation, sponsored by October 6 University.

Who is sponsoring NCT05217771?

NCT05217771 is sponsored by October 6 University.

What drugs are being tested in NCT05217771?

Interventions in NCT05217771: High tone power therapy group.

What condition does NCT05217771 study?

NCT05217771 studies Rehabilitation.

Is NCT05217771 still recruiting?

NCT05217771 is currently status unknown. Last updated 1 February 2022.

Last reviewed 2022-02-01 · How we verify

NCT05217771: WHO

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect Of High Tone Power Therapy On Selected Symptoms In Post Covid Syndrome

Status unknown NA Last updated 1 February 2022

What this trial tests

NA trial testing High tone power therapy group in Rehabilitation in 56 participants. Status unknown.

Timeline

10 November 2021

Primary endpoint
20 November 2022

20 November 2022

Quick facts

Lead sponsor	October 6 University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	56
Start date	10 November 2021
Primary completion	20 November 2022
Estimated completion	20 November 2022
Sites	1 location across Egypt

Drugs / interventions tested

High tone power therapy group

Conditions studied

Rehabilitation — all drugs for Rehabilitation →

Sponsor

October 6 University

Who can join

Adults 40 to 60, any sex, with Rehabilitation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The Coronavirus Disease 2019 (COVID-19) is a highly transmittable and pathogenic viral infection caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2), which emerged in Wuhan, China in December 2019 and its spread around the world has been rapid (Rathi et al., 2021; Vakili et al., 2021). COVID-19 impacts on economy, society, education , neurological, psychiatric and psychosocial impairments , increasing the burden of disease and disability throughout the world have been studied by several authors (Phillips et al., 2020; Pragholapati, 2020). COVID-19 may lead to greater risks of long-term scarring, permanently lower economic activity, a significant increase in the prevalence of chronic illness, social distancing, isolation, changes in teaching and learning strategies to decrease of number of days of education, the number of social contacts each day is limited (Minister \& Majesty, 2020; Almomani et al., 2021) .

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Rehabilitation

Currently open trials in the same condition.

NCT07450274 — Rehabilitation of Upper Limbs After Stroke · NA · recruiting
NCT07419217 — Professional Impact of Osteoarticular Trauma · recruiting
NCT07399262 — Music-Augmented Rhythmic Gait Training in Multiple Sclerosis · NA · recruiting
NCT07333079 — Rehabilitation With Biofeedback for People After Stroke · NA · recruiting
NCT07304180 — Exergame vs Balance Training in Hemiplegia · NA · active not recruiting

Other October 6 University trials

Trials by the same sponsor.

NCT07235072 — Passive Fit and Time Efficiency in All On-X Implants Protocols Using Photogrammetry, Splinted Scan Bodies, and Conventio · NA · not yet recruiting
NCT07403851 — Effect of Scanning Technology on the Accuracy of Digitally Customized Intraradicular Attachments · NA · not yet recruiting
NCT07305792 — High Tone Power Therapy on Lumbosacral Radiculopathy Patients · NA · completed
NCT07132736 — Impact of Underwater Exercise Versus Regular Aerobic Exercise on Quality of Life and Power of Muscle · NA · recruiting
NCT07350655 — Efficacy of Virtual Reality-based Training in Patients With Chronic Non-specific Low Back Pain · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05217771 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by October 6 University
Last refreshed: 1 February 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05217771.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing